Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma (Q39962447)

15 September 2017

title

Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma (English)

1 reference

15 September 2017

0 references

11

Barbara Jarzab

1 reference

15 September 2017

3

Michał Jarzab

1 reference

Malgorzata Oczko-Wojciechowska

15 September 2017

series ordinal

4

object named as

Małgorzata Oczko-Wojciechowska

1 reference

15 September 2017

8

Małgorzata Kowalska

1 reference

15 September 2017

10

Dariusz Lange

1 reference

15 September 2017

9

Zbigniew Wygoda

1 reference

15 September 2017

2

Tomasz Tyszkiewicz

1 reference

15 September 2017

5

Tatiana Gierek

1 reference

15 September 2017

Jarosław Markowski

1

1 reference

15 September 2017

Małgorzata Witkowska

series ordinal

6

1 reference

15 September 2017

Jarosław Paluch

series ordinal

7

1 reference

15 September 2017

language of work or name

1 reference

16 July 2009

1 reference

European Archives of Oto-Rhino-Laryngology

15 September 2017

published in

1 reference

15 September 2017

volume

266

1 reference

15 September 2017

issue

10

1 reference

15 September 2017

page(s)

1501-1507

1 reference

https://scigraph.springernature.com/pub.10.1007/s00405-009-1019-3

15 September 2017

exact match

0 references

cites work

ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00405-009-1019-3

Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers

21 January 2018

1 reference

12 December 2020

Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.

1 reference

12 December 2020

CHES1/FOXN3 interacts with Ski-interacting protein and acts as a transcriptional repressor

1 reference

12 December 2020

Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies.

1 reference

12 December 2020

Prognostic significance of histopathological parameters in cancer of the larynx

1 reference

12 December 2020

The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.

1 reference

12 December 2020

KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer

1 reference

12 December 2020

Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma.

1 reference

12 December 2020

Genomic screening of head and neck cancer and its implications for therapy planning

1 reference

12 December 2020

Molecular biology of squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells.

1 reference

12 December 2020

Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma

1 reference

12 December 2020

Molecular biomarkers in HNSCC: prognostic and therapeutic implications

1 reference

12 December 2020

Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays.

1 reference

12 December 2020

Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein

1 reference

12 December 2020

Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas

1 reference

12 December 2020

Molecular profiling of tumor progression in head and neck cancer

1 reference

12 December 2020

KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers

1 reference

12 December 2020

NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma

1 reference

12 December 2020

A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status

1 reference

12 December 2020

KIF14 mRNA expression is a predictor of grade and outcome in breast cancer

1 reference

12 December 2020

Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses

1 reference

12 December 2020

Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.

1 reference

12 December 2020

Gene expression profiles of head and neck carcinomas from Sudanese and Norwegian patients reveal common biological pathways regardless of race and lifestyle

1 reference

12 December 2020

Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1.

1 reference

12 December 2020

Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma

1 reference

12 December 2020

Identification of a gene signature for rapid screening of oral squamous cell carcinoma

1 reference

12 December 2020

10.1007/S00405-009-1019-3

Identifiers

DOI

1 reference

15 September 2017

1 reference